These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21541726)

  • 1. Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression.
    Achouitar S; Mohamed M; Gardeitchik T; Wortmann SB; Sykut-Cegielska J; Ensenauer R; de Baulny HO; Õunap K; Martinelli D; de Vries M; McFarland R; Kouwenberg D; Theodore M; Wijburg F; Grünewald S; Jaeken J; Wevers RA; Nijtmans L; Elson J; Morava E
    J Inherit Metab Dis; 2011 Aug; 34(4):923-7. PubMed ID: 21541726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment.
    Serrano M; de Diego V; Muchart J; Cuadras D; Felipe A; Macaya A; Velázquez R; Poo MP; Fons C; O'Callaghan MM; García-Cazorla A; Boix C; Robles B; Carratalá F; Girós M; Briones P; Gort L; Artuch R; Pérez-Cerdá C; Jaeken J; Pérez B; Pérez-Dueñas B
    Orphanet J Rare Dis; 2015 Oct; 10():138. PubMed ID: 26502900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes and quality of life in PMM2-CDG.
    Ligezka AN; Mohamed A; Pascoal C; Ferreira VDR; Boyer S; Lam C; Edmondson A; Krzysciak W; Golebiowski R; Perez-Ortiz J; Morava E
    Mol Genet Metab; 2022 Jun; 136(2):145-151. PubMed ID: 35491370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
    Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
    Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital disorders of glycosylation (CDG): it's (nearly) all in it!
    Jaeken J
    J Inherit Metab Dis; 2011 Aug; 34(4):853-8. PubMed ID: 21384229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG.
    Witters P; Tahata S; Barone R; Õunap K; Salvarinova R; Grønborg S; Hoganson G; Scaglia F; Lewis AM; Mori M; Sykut-Cegielska J; Edmondson A; He M; Morava E
    Genet Med; 2020 Jun; 22(6):1102-1107. PubMed ID: 32103184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scale to monitor progression and treatment of mitochondrial disease in children.
    Phoenix C; Schaefer AM; Elson JL; Morava E; Bugiani M; Uziel G; Smeitink JA; Turnbull DM; McFarland R
    Neuromuscul Disord; 2006 Dec; 16(12):814-20. PubMed ID: 17123819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital disorders of glycosylation (CDG): Quo vadis?
    Péanne R; de Lonlay P; Foulquier F; Kornak U; Lefeber DJ; Morava E; Pérez B; Seta N; Thiel C; Van Schaftingen E; Matthijs G; Jaeken J
    Eur J Med Genet; 2018 Nov; 61(11):643-663. PubMed ID: 29079546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Western blotting with diaminobenzidine detection for the diagnosis of congenital disorders of glycosylation.
    Artuch R; Ferrer I; Pineda J; Moreno J; Busquets C; Briones P; Vilaseca MA
    J Neurosci Methods; 2003 May; 125(1-2):167-71. PubMed ID: 12763243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALG11-CDG syndrome: Expanding the phenotype.
    Haanpää MK; Ng BG; Gallant NM; Singh KE; Brown C; Kimonis V; Freeze HH; Muller EA
    Am J Med Genet A; 2019 Mar; 179(3):498-502. PubMed ID: 30676690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socio-emotional Problems in Children with CDG.
    van de Loo KF; van Dongen L; Mohamed M; Gardeitchik T; Kouwenberg TW; Wortmann SB; Rodenburg RJ; Lefeber DJ; Morava E; Verhaak CM
    JIMD Rep; 2013; 11():139-48. PubMed ID: 23733602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.
    Medrano C; Vega A; Navarrete R; Ecay MJ; Calvo R; Pascual SI; Ruiz-Pons M; Toledo L; García-Jiménez I; Arroyo I; Campo A; Couce ML; Domingo-Jiménez MR; García-Silva MT; González-Gutiérrez-Solana L; Hierro L; Martín-Hernández E; Martínez-Pardo M; Roldán S; Tomás M; Cabrera JC; Mártinez-Bugallo F; Martín-Viota L; Vitoria-Miñana I; Lefeber DJ; Girós ML; Serrano Gimare M; Ugarte M; Pérez B; Pérez-Cerdá C
    Clin Genet; 2019 May; 95(5):615-626. PubMed ID: 30653653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic.
    Damen G; de Klerk H; Huijmans J; den Hollander J; Sinaasappel M
    J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):282-7. PubMed ID: 15076627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation.
    Cylwik B; Naklicki M; Chrostek L; Gruszewska E
    Acta Biochim Pol; 2013; 60(2):151-61. PubMed ID: 23730680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.
    Jones MA; Rhodenizer D; da Silva C; Huff IJ; Keong L; Bean LJ; Coffee B; Collins C; Tanner AK; He M; Hegde MR
    Mol Genet Metab; 2013; 110(1-2):78-85. PubMed ID: 23806237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital defects of glycosylation: Novel presentations with mainly neurological involvement and variable dysmorphic features.
    İnci A; Cengiz B; Biberoğlu G; Okur İ; Arhan E; Öner AY; Kasapkara ÇS; Küçükçongar A; Tümer L; Ezgu F
    Am J Med Genet A; 2021 Sep; 185(9):2739-2747. PubMed ID: 33960646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation.
    Sturiale L; Barone R; Garozzo D
    J Inherit Metab Dis; 2011 Aug; 34(4):891-9. PubMed ID: 21384227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital disorders of glycosylation.
    Jaeken J
    Handb Clin Neurol; 2013; 113():1737-43. PubMed ID: 23622397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.